Goldman Sachs’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Buy
217,878
+52,952
+32% +$615K ﹤0.01% 4133
2025
Q4
$1.58M Buy
164,926
+99,951
+154% +$957K ﹤0.01% 4786
2025
Q3
$611K Buy
64,975
+39,030
+150% +$373K ﹤0.01% 5375
2025
Q2
$274K Sell
25,945
-26,039
-50% -$329K ﹤0.01% 5493
2025
Q1
$781K Sell
51,984
-16,701
-24% -$278K ﹤0.01% 4880
2024
Q4
$1.13M Sell
68,685
-20,042
-23% -$395K ﹤0.01% 4737
2024
Q3
$2.19M Buy
88,727
+13,870
+19% +$360K ﹤0.01% 4084
2024
Q2
$1.9M Sell
74,857
-2,073
-3% -$53.7K ﹤0.01% 3961
2024
Q1
$1.95M Sell
76,930
-3,812
-5% -$92.2K ﹤0.01% 3880
2023
Q4
$1.83M Sell
80,742
-1,762
-2% -$36.5K ﹤0.01% 3993
2023
Q3
$1.54M Buy
82,504
+22,213
+37% +$461K ﹤0.01% 3967
2023
Q2
$1.57M Buy
60,291
+10,185
+20% +$273K ﹤0.01% 4048
2023
Q1
$1.44M Buy
50,106
+3,711
+8% +$110K ﹤0.01% 4114
2022
Q4
$1.37M Sell
46,395
-21,633
-32% -$615K ﹤0.01% 4212
2022
Q3
$1.62M Sell
68,028
-79,669
-54% -$1.83M ﹤0.01% 4153
2022
Q2
$3.3M Buy
147,697
+46,780
+46% +$1.04M ﹤0.01% 3580
2022
Q1
$2.53M Buy
100,917
+90,029
+827% +$2.74M ﹤0.01% 4025
2021
Q4
$390K Sell
10,888
-19,325
-64% -$774K ﹤0.01% 5526
2021
Q3
$1.29M Sell
30,213
-17,577
-37% -$724K ﹤0.01% 4557
2021
Q2
$2.07M Buy
47,790
+2,523
+6% +$107K ﹤0.01% 4173
2021
Q1
$1.85M Sell
45,267
-22,720
-33% -$862K ﹤0.01% 4070
2020
Q4
$3.08M Sell
67,987
-32,643
-32% -$1.24M ﹤0.01% 3402
2020
Q3
$3.56M Sell
100,630
-23,627
-19% -$853K ﹤0.01% 3150
2020
Q2
$4.69M Sell
124,257
-99,317
-44% -$3.27M ﹤0.01% 2842
2020
Q1
$6.46M Sell
223,574
-86,302
-28% -$3.49M ﹤0.01% 2436
2019
Q4
$16.1M Buy
309,876
+138,695
+81% +$8.06M ﹤0.01% 2045
2019
Q3
$9.4M Sell
171,181
-56,818
-25% -$2.92M ﹤0.01% 2371
2019
Q2
$9.26M Buy
227,999
+150,641
+195% +$5.49M ﹤0.01% 2414
2019
Q1
$2.34M Buy
77,358
+569
+0.7% +$19.5K ﹤0.01% 3535
2018
Q4
$2.58M Sell
76,789
-9,782
-11% -$353K ﹤0.01% 3370
2018
Q3
$3.65M Sell
86,571
-39,721
-31% -$1.57M ﹤0.01% 3202
2018
Q2
$4.04M Sell
126,292
-22,422
-15% -$923K ﹤0.01% 3106
2018
Q1
$7.39M Sell
148,714
-1,929
-1% -$109K ﹤0.01% 2596
2017
Q4
$8.12M Sell
150,643
-8,444
-5% -$467K ﹤0.01% 2622
2017
Q3
$9.23M Buy
159,087
+127,915
+410% +$6.69M ﹤0.01% 2622
2017
Q2
$1.54M Sell
31,172
-4,402
-12% -$203K ﹤0.01% 4060
2017
Q1
$1.54M Sell
35,574
-8,851
-20% -$423K ﹤0.01% 4000
2016
Q4
$2.17M Sell
44,425
-20,039
-31% -$926K ﹤0.01% 3775
2016
Q3
$3.08M Buy
64,464
+57,762
+862% +$2.85M ﹤0.01% 3448
2016
Q2
$360K Sell
6,702
-3,201
-32% -$151K ﹤0.01% 5180
2016
Q1
$443K Sell
9,903
-7,517
-43% -$305K ﹤0.01% 4863
2015
Q4
$665K Sell
17,420
-3,178
-15% -$122K ﹤0.01% 4675
2015
Q3
$656K Buy
+20,598
New +$718K ﹤0.01% 4883
2015
Q2
Sell
-16,910
Closed -$696K 7240
2015
Q1
$696K Sell
16,910
-13,513
-44% -$546K ﹤0.01% 4813
2014
Q4
$1.24M Sell
30,423
-17,367
-36% -$679K ﹤0.01% 4341
2014
Q3
$1.75M Buy
47,790
+7,662
+19% +$331K ﹤0.01% 4069
2014
Q2
$1.86M Buy
40,128
+9,153
+30% +$407K ﹤0.01% 4056
2014
Q1
$1.27M Buy
30,975
+6,788
+28% +$252K ﹤0.01% 4430
2013
Q4
$923K Buy
24,187
+15,032
+164% +$464K ﹤0.01% 4804
2013
Q3
$219K Buy
+9,155
New +$205K ﹤0.01% 5801

Other funds holding ANIK